Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
CHF-6333 by Chiesi Farmaceutici for Cystic Fibrosis: Likelihood of Approval
CHF-6333 is under clinical development by Chiesi Farmaceutici and currently in Phase I for Cystic Fibrosis. According to GlobalData, Phase...
Data Insights
CHF-6333 by Chiesi Farmaceutici for Bronchiectasis: Likelihood of Approval
CHF-6333 is under clinical development by Chiesi Farmaceutici and currently in Phase II for Bronchiectasis. According to GlobalData, Phase II...